Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma.

Prukova D, Andera L, Nahacka Z, Karolova J, Svaton M, Klanova M, Havranek O, Soukup J, Svobodova K, Zemanova Z, Tuskova D, Pokorna E, Helman K, Forsterova K, Pacheco-Blanco M, Vockova P, Berkova A, Fronkova E, Trneny M, Klener P.

Clin Cancer Res. 2019 Apr 19. doi: 10.1158/1078-0432.CCR-18-3275. [Epub ahead of print]

PMID:
31004002
2.

Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse.

Klimova A, Heissigerova J, Rihova E, Brichova M, Pytlik R, Spicka I, Mrazova K, Karolova J, Svozilkova P.

Br J Ophthalmol. 2018 Nov;102(11):1579-1585. doi: 10.1136/bjophthalmol-2017-311574. Epub 2018 Jan 29.

PMID:
29378728

Supplemental Content

Loading ...
Support Center